Xtant Medical Holdings, Inc. (XTNT): Price and Financial Metrics
XTNT Price/Volume Stats
Current price | $0.64 | 52-week high | $1.20 |
Prev. close | $0.61 | 52-week low | $0.43 |
Day low | $0.61 | Volume | 3,708 |
Day high | $0.65 | Avg. volume | 41,384 |
50-day MA | $0.63 | Dividend yield | N/A |
200-day MA | $0.66 | Market Cap | 69.28M |
XTNT Stock Price Chart Interactive Chart >
XTNT Stock Summary
- XTANT MEDICAL HOLDINGS INC's market capitalization of $72,961,022 is ahead of only 18.28% of US-listed equities.
- Of note is the ratio of XTANT MEDICAL HOLDINGS INC's sales and general administrative expense to its total operating expenses; 83.54% of US stocks have a lower such ratio.
- XTANT MEDICAL HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -18.65%, greater than the shareholder yield of only 19% of stocks in our set.
- Stocks that are quantitatively similar to XTNT, based on their financial statements, market capitalization, and price volatility, are NVFY, BARK, IVDA, IDXG, and HURC.
- XTNT's SEC filings can be seen here. And to visit XTANT MEDICAL HOLDINGS INC's official web site, go to www.xtantmedical.com.
XTNT Valuation Summary
- XTNT's price/sales ratio is 1.1; this is 78.43% lower than that of the median Healthcare stock.
- Over the past 157 months, XTNT's EV/EBIT ratio has gone down 793.3.
Below are key valuation metrics over time for XTNT.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
XTNT | 2023-05-23 | 1.1 | 2.1 | -8.2 | -13.3 |
XTNT | 2023-05-22 | 1.1 | 2.1 | -8.2 | -13.2 |
XTNT | 2023-05-19 | 1.1 | 2.1 | -8.3 | -13.5 |
XTNT | 2023-05-18 | 1.0 | 2.0 | -7.8 | -12.8 |
XTNT | 2023-05-17 | 1.1 | 2.1 | -8.2 | -13.3 |
XTNT | 2023-05-16 | 1.1 | 2.1 | -8.2 | -13.2 |
XTNT Growth Metrics
- Its 4 year price growth rate is now at -88.13%.
- The 5 year price growth rate now stands at -88.13%.
- The 3 year revenue growth rate now stands at -21.57%.

The table below shows XTNT's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 56.668 | -2.63 | -8.559 |
2022-06-30 | 55.983 | -1.492 | -8.01 |
2022-03-31 | 55.681 | 0.742 | -7.033 |
2021-12-31 | 55.263 | 0.439 | -4.849 |
2021-09-30 | 55.309 | 0.932 | -3.272 |
2021-06-30 | 55.548 | 1.787 | -2.828 |
Xtant Medical Holdings, Inc. (XTNT) Company Bio
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company is based in Montana.
Latest XTNT News From Around the Web
Below are the latest news stories about XTANT MEDICAL HOLDINGS INC that investors may wish to consider to help them evaluate XTNT as an investment opportunity.
Xtant Medical Appoints Lori Mitchell-Keller to Board of DirectorsBELGRADE, Mont., May 18, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Lori Mitchell-Keller to the Company's Board of Directors effective May 16, 2023. Ms. Mitchell-Keller will serve as a member of the Compensation and Audit Committees of the Board of Directors. “We are pleased to welcome Lori to our Board, marking another high |
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2023 Earnings Call TranscriptXtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2023 Earnings Call Transcript May 6, 2023 Operator: Greetings. You’re welcome Xtant Medical’s Q1 2023 financial results call. . As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Matt Steinberg of Lazar FINN Partners. Please go ahead. Matt […] |
Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue GuidanceInitiates Annual Revenue Guidance of $73 Million - $75 Million in Full Year 2023 BELGRADE, Mont., May 04, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2023. The Company also introduced financial guidance for the full year 2023. “Highlighted by solid revenue growth and the Cofle |
Xtant Medical to Issue First Quarter 2023 Financial Results on May 4, 2023BELGRADE, Mont., April 27, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2023, before the open of the financial markets on Thursday, May 4, 2023. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call |
Q4 2022 Xtant Medical Holdings Inc Earnings CallQ4 2022 Xtant Medical Holdings Inc Earnings Call |
XTNT Price Returns
1-mo | 3.23% |
3-mo | -45.76% |
6-mo | 6.93% |
1-year | 11.28% |
3-year | -47.97% |
5-year | -87.99% |
YTD | -3.03% |
2022 | 17.86% |
2021 | -53.18% |
2020 | -25.24% |
2019 | -0.62% |
2018 | -76.46% |
Continue Researching XTNT
Want to see what other sources are saying about Xtant Medical Holdings Inc's financials and stock price? Try the links below:Xtant Medical Holdings Inc (XTNT) Stock Price | Nasdaq
Xtant Medical Holdings Inc (XTNT) Stock Quote, History and News - Yahoo Finance
Xtant Medical Holdings Inc (XTNT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...